Results 261 to 270 of about 4,775,633 (379)

Clinical Pathophysiological Study of Venous Blood Gas Partial Pressures and pH of Organs in Various Diseases

, 1974
Takeshi Miyazawa
openalex   +2 more sources

The influence of venous pressure upon the heart‐rate

Journal of Physiology, 1920
K. Sassa, H. Miyazaki
semanticscholar   +1 more source

Factors Driving Battery and Solar Purchase Decision of Residents: a Behavioural Choice Experiment Using a Hybrid Discrete Choice and Latent Variable Model

Advanced Sustainable Systems, EarlyView.
This article explores what drives households to adopt solar PV and battery systems in South East Queensland. Using hybrid discrete choice experiments, it reveals distinct adopter profiles and highlights cost, system size, and energy independence as key motivators.
Mohammad Alipour, Elnaz Irannezhad, Rodney A. Stewart, Oz Sahin   +3 more
wiley   +1 more source

Heterogeneity Landscape of Circulating Tumor Cells in Clinical Utility

Advanced Therapeutics, EarlyView.
This study reports the heterogeneity spectrum of circulating tumor cells. The factors involved in the spectrum promote CTCs to overcome barriers in the metastatic cascade but impact the clinical outcome of cancer patients. In summary, the heterogeneities in association with CTCs ultimately reduce patient survival and facilitate increasing mortality of ...
Md Kowsar Alam, Lu Yanjun, Bee Luan Khoo, Tongxu Si, Heng Zou, Mengsu Yang   +5 more
wiley   +1 more source

Changes in central venous pressure during a fluid challenge have limited value for guiding fluid therapy. [PDF]

Crit Care Sci
de Oliveira PS, Ramos FJDS, Tomotani DYV, Machado FR, de Freitas FGR.   +4 more
europepmc   +1 more source

Simultaneous Monitoring of Central Venous and Swan-Ganz Pressures

, 1975
Denis L. Bourke, JEFFREY LAWRENCE
openalex   +1 more source

Microphysiological Systems in Cancer Research: Advancing Immunotherapy through Tumor Microenvironment‐Integrated Organ‐On‐Chip Models

Advanced Therapeutics, EarlyView.
Emerging microphysiological systems reproduce the spatial, biochemical, and cellular complexity of the tumor microenvironment, surpassing 2D cultures and murine models. By integrating patient‐derived tumors, perfusable vasculature, and immune trafficking, these organ‐on‐chip platforms reveal mechanisms of immune evasion, predict therapeutic responses ...
Fabiana Moresi, Francesco Noto, Jyothsna Vasudevan, Xavier Bisteau, Giulia Adriani, Andrea Pavesi   +5 more
wiley   +1 more source

Correction: Central venous pressure and dynamic indices to assess fluid appropriateness in critically ill patients: A pilot study. [PDF]

PLoS One
Prezioso C, Trotta R, Cavallo E, Fusina F, Malpetti E, Albani F, Caserta R, Rosano A, Natalini G.   +8 more
europepmc   +1 more source

Normal central venous pressure

Journal of British Surgery, 1968
E. Sagay, S. M. N. Jaikaran
openaire   +3 more sources

Evolution of Ocular Organ‐On‐Chip Systems for Disease Modelling and Drug Testing: Where are We Now?

Advanced Therapeutics, EarlyView.
The rise in ophthalmic diseases due to aging, screen use, and environmental factors has driven demand for better ocular models. Traditional systems fall short, encouraging the development of organ‐on‐chip devices. These microfluidic platforms replicate eye tissue architecture, enable drug screening, and simulate ocular diseases.
Sara Trujillo
wiley   +1 more source